Ponsegromab: The new miracle drug for cancer cachexia

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Indian Journal of Pharmacology

• Publication date

  2025-10-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/ijp.ijp_347_25PMID 41221573PMCID 12662614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ponsegromab for the Treatment of Cancer Cachexia.

  2024cited by this paper
• The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?

  2020cited by this paper
• Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.

  2016cited by this paper
• Definition and classification of cancer cachexia: an international consensus.

  2011cited by this paper
• [Megestrol acetate: a systematic review usefulness about the weight gain in neoplastic patients with cachexia].

  2002cited by this paper
• Acetato de megestrol: una revisión sistemática de su utilidad clínica para la ganancia de peso en los enfermos con neoplasia y caquexia

  2002cited by this paper

• No citing papers are available for this paper.